Regenxbio Stock Story
RGNX Stock | USD 21.67 0.08 0.37% |
Slightly above 59% of all Regenxbio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Regenxbio suggests that some traders are interested. Regenxbio's investor sentiment overview provides quick insight into current market opportunities from investing in Regenxbio. The current market sentiment, together with Regenxbio's historical and current headlines, can help investors time the market. In addition, many technical investors use Regenxbio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Regenxbio stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Regenxbio daily returns and investor perception about the current price of Regenxbio as well as its diversification or hedging effects on your existing portfolios.
Regenxbio |
Requested story not found. it has been either deleted or moved. View all stories for Regenxbio.
Regenxbio Latest Timeline
Regenxbio is listed for 21.67. About 83.0% of the company shares are owned by institutional investors. The book value of Regenxbio was at this time reported as 7.08. The company has Price/Earnings To Growth (PEG) ratio of 0.26. Regenxbio recorded a loss per share of 6.02. The entity had not issued any dividends in recent years.Check out Regenxbio Hype Analysis, Regenxbio Correlation and Regenxbio Performance. For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Regenxbio Stock analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Regenxbio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regenxbio. If investors know Regenxbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regenxbio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.02) | Revenue Per Share 2.063 | Quarterly Revenue Growth (0.29) | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Regenxbio is measured differently than its book value, which is the value of Regenxbio that is recorded on the company's balance sheet. Investors also form their own opinion of Regenxbio's value that differs from its market value or its book value, called intrinsic value, which is Regenxbio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regenxbio's market value can be influenced by many factors that don't directly affect Regenxbio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regenxbio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regenxbio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regenxbio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.